Octarine Bio

Copenhagen, Denmark · Founded 2018 · Privately Held (backing)

Developer of cannabinoids and psilocybin derivatives intended to improve the health and well-being of people. Octarine Bio is based in Copenhagen, Denmark and was founded in 2018. Its last reported valuation was $30.8 million in Jan 2026. It has raised $16.8 million.

Last reported valuation
$30.8M
Oct 2026
Priced at
—
Total raised
$16.8M
Last round
—

Who backs Octarine Bio?

16 investors
InvestorType
InnoFounderOther
Denmark's Export and Investment FundVenture capital
BioInnovation InstituteOther
Unconventional VenturesOther
Bruce Linton—
CMH Home Health Care—
Canopy Growth—
DSM-Firmenich—
Edaphon—
Enexis (Sweden)—
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Octarine Bio investors

16 investors are on record for Octarine Bio, including InnoFounder, Denmark's Export and Investment Fund, BioInnovation Institute and Unconventional Ventures.

Free account
More of Octarine Bio with a free account
  • ·The complete investor list: 16 names
  • ·Watch Octarine Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like Octarine Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View